Corticostatins/defensins inhibit in vitro NK activity and cytokine production by human peripheral blood mononuclear cells.
Corticostatins/defensins are a family of cationic peptides recently isolated from phagocytotic cells of the myeloid lineage. Natural killer (NK) cells are spontaneously cytotoxic large granular lymphocytes that are involved in immunosurveillance against cancer and infections. Their activity is modulated by hormones of the hypothalamic-pituitary-adrenal axis. We wished to determine whether two human corticostatins/defensins, HP-1 and HP-4, are able to change in vitro the spontaneous NK activity of human peripheral blood mononuclear cells (PBMC) and the responses either to the stimulatory cytokines immune interferon (IFN-gamma) or interleukin 2 (IL-2) and to the inhibitory hormone cortisol. NK cell activity was measured in a 4-h direct cytotoxicity assay with K562 cells as a target. HP-1 and HP-4 (10 (-8) -10 (-9) M) significantly inhibited the spontaneous and cytokine-inducible NK activity, and increased the cortisol-dependent inhibition. Radioimmunoassay of HPLC purified fractions obtained from sonicated NK cells showed HP-1 in the two cell preparations examined. We also evaluated the effects of HP-1 and HP-4 (10 (-8) M -10(-9) M) upo IFN-gamma and interleukin 6 (IL-6) production by PBMC stimulated with phytohemagglutinin (PHA) or concanavalin A (ConA). IFN-gamma was titrated with the biological assay using WISH cells as indicators and vescicular stomatitis virus (VSV) as the challenge virus. IL-6 was measured using an enzyme amplified sensitivity immunoassay. Both HP-1 and HP-4 significantly reduced cytokine production. Our data indicate that corticostatins/defensins are novel modulators of lymphocyte functions in vitro. Their immunodepressing properties could add complexity and plasticity to hypothalamic-pituitary-adrenal-cytokine circuits in vivo.
Masera
R G
RG
Dipartimento di Scienze Cliniche e Biologiche, Università di Torina, Italy.
Bateman
A
A
Muscettola
M
M
Solomon
S
S
Angeli
A
A
D000311:Adrenal Glands / Q000378:metabolism; D000704:Analysis of Variance; D000818:Animals; D000890:Anti-Infective Agents / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D000917:Antibody Formation; D001798:Blood Proteins / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D003208:Concanavalin A / Q000494:pharmacology; D016207:Cytokines / Q000096:biosynthesis*; D023082:Defensins; D006727:Hormone Antagonists / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D007031:Hypothalamus / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins; D007371:Interferon-gamma / Q000096:biosynthesis / Q000494:pharmacology; D007376:Interleukin-2 / Q000494:pharmacology; D015850:Interleukin-6 / Q000096:biosynthesis; D007694:Killer Cells, Natural / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D010455:Peptides / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D010835:Phytohemagglutinins / Q000494:pharmacology; D010902:Pituitary Gland / Q000378:metabolism; D011817:Rabbits; D011863:Radioimmunoassay; D011994:Recombinant Proteins / Q000494:pharmacology; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D023084:alpha-Defensins
D000890:Anti-Infective Agents; D001798:Blood Proteins; D016207:Cytokines; D023082:Defensins; D006727:Hormone Antagonists; D036341:Intercellular Signaling Peptides and Proteins; D007376:Interleukin-2; D015850:Interleukin-6; D010455:Peptides; D010835:Phytohemagglutinins; D011994:Recombinant Proteins; D023084:alpha-Defensins; C406413:human neutrophil peptide 1; C406428:human neutrophil peptide 4; D003208:Concanavalin A; C054598:corticostatin; D007371:Interferon-gamma; D006854:Hydrocortisone